Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GABA transmission is the process by which gamma-aminobutyric acid (GABA), the primary inhibitory neurotransmitter in the mammalian central nervous system, mediates its effects. This involves GABA synthesis, release, receptor binding (GABAA and GABAB), and subsequent neuronal inhibition, playing a crucial role in regulating neuronal excitability and preventing overstimulation of the nervous system. Dysregulation of GABA transmission is implicated in various neurological and psychiatric disorders, making it a target for therapeutic intervention.
Enhancement or mimicry of GABA's inhibitory effects via various mechanisms including positive allosteric modulation of GABA receptors, GABA receptor agonism, or increasing GABA levels/efficacy.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gamma-Aminobutyric Acid Transmission (GABA).